These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 25442813)
1. Prognostic factors for patients with advanced colorectal cancer and symptomatic brain metastases. Tokoro T; Okuno K; Hida JC; Ueda K; Yoshifuji T; Daito K; Sugiura F Clin Colorectal Cancer; 2014 Dec; 13(4):226-31. PubMed ID: 25442813 [TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer metastatic to the brain: time trends in presentation and outcome. Nieder C; Pawinski A; Balteskard L Oncology; 2009; 76(5):369-74. PubMed ID: 19321946 [TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary treatment of brain metastases derived from colorectal cancer incorporating stereotactic radiosurgery: analysis of 78 patients. Fokas E; Henzel M; Hamm K; Surber G; Kleinert G; Engenhart-Cabillic R Clin Colorectal Cancer; 2011 Jun; 10(2):121-5. PubMed ID: 21859565 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723 [TBL] [Abstract][Full Text] [Related]
6. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease. Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675 [TBL] [Abstract][Full Text] [Related]
7. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. Ammori JB; Kemeny NE; Fong Y; Cercek A; Dematteo RP; Allen PJ; Kingham TP; Gonen M; Paty PB; Jarnagin WR; D'Angelica MI Ann Surg Oncol; 2013 Sep; 20(9):2901-7. PubMed ID: 23771246 [TBL] [Abstract][Full Text] [Related]
8. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Meier S; Baumert BG; Maier T; Wellis G; Burg G; Seifert B; Dummer R Onkologie; 2004 Apr; 27(2):145-9. PubMed ID: 15138346 [TBL] [Abstract][Full Text] [Related]
9. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Paek SH; Audu PB; Sperling MR; Cho J; Andrews DW Neurosurgery; 2005 May; 56(5):1021-34; discussion 1021-34. PubMed ID: 15854250 [TBL] [Abstract][Full Text] [Related]
10. Brain metastases from colorectal cancer: characteristics and management. Mege D; Sans A; Ouaissi M; Iannelli A; Sielezneff I ANZ J Surg; 2018 Mar; 88(3):140-145. PubMed ID: 28687024 [TBL] [Abstract][Full Text] [Related]
11. Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection. Rades D; Veninga T; Hornung D; Wittkugel O; Schild SE; Gliemroth J Cancer; 2012 Feb; 118(4):1138-44. PubMed ID: 21761403 [TBL] [Abstract][Full Text] [Related]
13. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983 [TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853 [TBL] [Abstract][Full Text] [Related]
15. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases. Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817 [TBL] [Abstract][Full Text] [Related]
16. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience. Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765 [TBL] [Abstract][Full Text] [Related]
17. Abdominal desmoplastic small round cell tumor: multimodal treatment combining chemotherapy, surgery, and radiotherapy is the best option. Honoré C; Amroun K; Vilcot L; Mir O; Domont J; Terrier P; Le Cesne A; Le Péchoux C; Bonvalot S Ann Surg Oncol; 2015 Apr; 22(4):1073-9. PubMed ID: 25300608 [TBL] [Abstract][Full Text] [Related]
18. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases. Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer. Turan N; Benekli M; Koca D; Ustaalioglu BO; Dane F; Ozdemir N; Ulas A; Oztop I; Gumus M; Ozturk MA; Berk V; Kucukoner M; Uner A; Balakan O; Helvaci K; Ozkan S; Yilmaz U; Buyukberber S; Oncology; 2013; 84(1):14-21. PubMed ID: 23076023 [TBL] [Abstract][Full Text] [Related]